Artificial intelligence can elevate pharma manufacturing According to a leader from industrial AI specialist AspenTech, AI can help avoid costly maintenance interruptions by predicting when upkeep is needed. Any unnecessary downtime can be expensive for pharmaceutical manufacturing operations. What’s more, unplanned stoppages can delay the delivery of much-needed product, potentially causing damage to a company’s reputation. David Leitham, senior vice president and general manager at industrial artificial intelligence (AI) technology firm AspenTech, recently spoke with Outsourcing-Pharma (OSP) about how AI can be put to use to help predict when maintenance is needed, and avoid unplanned or over-maintenance. OSP: Could you please share an ‘elevator presentation’ description of AspenTech?